ABSTRACT
Due to the constantly growing geriatric population and the projected increase of the prevalence of chronic diseases that are refractory to drugs, implantable medical devices (IMDs) such as neurostimulators, endoscopic capsules, artificial retinal prostheses, and brain-machine interfaces are being developed. According to many business forecast firms, the IMD market is expected to grow and they are subject to much research aiming to overcome the numerous challenges of their development. One of these challenges consists of designing a wireless power and data transmission system that has high power efficiency, high data rates, low power consumption, and high robustness against noise. This is in addition to minimal design and implementation complexity. This manuscript concerns a comprehensive survey of the latest techniques used to power up and communicate between an external base station and an IMD. Patient safety considerations related to biological, physical, electromagnetic, and electromagnetic interference concerns for wireless IMDs are also explored. The simultaneous powering and data communication techniques using a single inductive link for both power transfer and bidirectional data communication, including the various data modulation/demodulation techniques, are also reviewed. This review will hopefully contribute to the persistent efforts to implement compact reliable IMDs while lowering their cost and upsurging their benefits.
Subject(s)
Chronic Disease/therapy , Implantable Neurostimulators/trends , Infusion Pumps, Implantable/trends , Wireless Technology/trends , Brain-Computer Interfaces/trends , Capsule Endoscopes/trends , Humans , Visual Prosthesis/trendsABSTRACT
Magnetically controlled capsule gastroscopy (MCCG) is a novel system primarily used for the diagnosis of gastric disease. It consists of an endoscopic capsule with magnetic material inside, external guidance magnet equipment, data recorder and computer workstation. Several clinical trials have demonstrated that MCCG is comparable in accuracy in diagnosing gastric focal disease when compared to conventional gastroscopy. Further clinical studies are needed to test the diagnostic accuracy and improve the functioning of MCCG. This novel MCCG system could be a promising alternative for screening for gastric diseases, with the advantages of no anesthesia required, comfort and high acceptance across populations.
Subject(s)
Capsule Endoscopy/trends , Stomach Diseases/diagnosis , Capsule Endoscopes/classification , Capsule Endoscopes/trends , Capsule Endoscopy/instrumentation , Gastroscopy/trends , Humans , Magnetics , Safety , Sensitivity and SpecificityABSTRACT
Background and aims: Small bowel submucosal lesions (SBSL) and innocent bulges may have an identical appearance and be difficult to distinguish on small bowel capsule endoscopy (SBCE). Recently, Girelli et al. proposed a score, smooth, protruding lesion index on capsule endoscopy (SPICE), in order to differentiate between the two. We aimed to evaluate and validate SPICE as a differentiation method between innocent bulges and SBSLs. Methods: We evaluated all SBCEs performed in our department between January 2005 and September 2015, and selected the ones with a smooth, round, protruding lesion in the small bowel. Lesions with suspicious characteristics were excluded. A video clip of the region of interest was created and SPICE was assigned blindly and independently by two endoscopists. We determined the discriminative ability of SPICE using the definitive diagnosis of each patient as the standard criteria. Results: We included 30 SBCEs corresponding to 12 SBSLs (four gastrointestinal stromal tumors, two neuroendocrine tumors, four lipomas and two polypoid lymphangiectasias) and 18 innocent bulges. SPICE scores ranged from 0 to 4, allowing the distinction between SBSLs and innocent bulges (p < 0.001). SPICE > 2 had a 66.7% sensitivity, 100.0% specificity, 100.0% positive predictive value and 78.3% negative predictive value, and the area under the curve was 0.88 (95% CI, 0.73-1.00; p < 0.001) for the diagnosis of SBSL. Conclusions: Our data support SPICE, namely a score > 2, as a predictive method of SBSLs. Taking into account its simplicity, it may be very useful in the distinction between SBSLs and innocent bulges on SBCE (AU)
No disponible
Subject(s)
Humans , Male , Female , Capsule Endoscopes/trends , Capsule Endoscopes , Intestinal Neoplasms , Decision Support Techniques , Intestine, Small/injuries , Capsule Endoscopes/adverse effects , 28599 , Lipoma , Intestine, Small/pathology , Intestine, Small , Retrospective StudiesABSTRACT
No disponible
Subject(s)
Humans , Female , Aged , Carcinoma, Renal Cell/complications , Carcinoma, Renal Cell/pathology , Carcinoma, Renal Cell , Neoplasm Metastasis/pathology , Neoplasm Metastasis , Capsule Endoscopes/trends , Capsule Endoscopes , Jejunum/pathology , Jejunum , Jejunal Neoplasms/pathology , Jejunal Neoplasms , Polyps/pathology , PolypsABSTRACT
INTRODUCCIÓN: el uso de la enteroscopia con videocápsula fue aprobado por la FDA en 2001. La hemorragia digestiva y la enfermedad inflamatoria intestinal son sus principales indicaciones. En nuestro centro se realiza desde 2004. MATERIAL Y MÉTODOS: Hemos recogido de forma retrospectiva los pacientes tratados mediante cápsula de intestino delgado desde octubre de 2004 hasta abril de 2015. Las indicaciones se han dividido en grupos: hemorragia digestiva de origen oscuro, tanto oculta como manifiesta; enfermedad inflamatoria intestinal; otras indicaciones. Los hallazgos se han dividido: lesiones vasculares; lesiones inflamatorias; otras lesiones; estudios normales; estudios no concluyentes. RESULTADOS: De un total de 1.291 estudios se ha incluido 1.027 en el análisis. La edad media es 56,45 años, con 471 hombres y 556 mujeres. La enfermedad más frecuentemente observada fueron las lesiones vasculares, asociadas o no a otras lesiones. Cuando la indicación era una hemorragia digestiva, el impacto diagnóstico fue del 80%. En la enfermedad inflamatoria esta cifra solo alcanza el 50%. El rendimiento diagnóstico es mucho menor en el grupo de «otras indicaciones». No se han registrado complicaciones mayores. DISCUSIÓN: La cápsula de intestino delgado tiene un alto rendimiento diagnóstico en los casos de hemorragia digestiva; el número de estudios con hallazgos positivos es menor en los de enfermedad inflamatoria intestinal. CONCLUSIONES: Se trata de una modalidad diagnóstica segura y de gran utilidad para el diagnóstico de enfermedad del intestino delgado, aunque se precisa mejorar el índice de sospecha en la enfermedad inflamatoria intestinal
INTRODUCTION: Capsule endoscopy was approved by the FDA in 2001. Gastrointestinal bleeding and inflammatory bowel disease are the main indications. It has been available in our hospital since 2004. METHODS: We retrospectively analysed data from patients who underwent small bowel capsule endoscopy in our hospital from October 2004 to April 2015. Indications were divided into: Obscure gastrointestinal bleeding (occult and overt), inflammatory bowel disease, and other indications. Findings were divided into: Vascular lesions, inflammatory lesions, other lesions, normal studies, and inconclusive studies. RESULTS: A total of 1027 out of 1291 small bowel studies were included. Mean patient age was 56.45 years; 471 were men and 556 women. The most common lesion observed was angiectasia, as an isolated finding or associated with other lesions. Findings were significant in up to 80% of studies when the indication was gastrointestinal bleeding, but in only 50% of studies in inflammatory bowel disease. Diagnostic yield was low in the group «other indications». No major complications were reported. DISCUSSION: Small bowel capsule endoscopy has high diagnostic yield in patients with gastrointestinal bleeding, but yield is lower in patients with inflammatory bowel disease. CONCLUSIONS: Our experience shows that capsule endoscopy is a safe and useful tool for the diagnosis of small bowel disease. The diagnostic yield of the technique in inflammatory bowel disease must be improved
Subject(s)
Humans , Inflammatory Bowel Diseases/diagnosis , Intestine, Small/physiopathology , Capsule Endoscopy/trends , Capsule Endoscopes/trends , Tertiary Healthcare , Endoscopy, Digestive System/methods , Gastrointestinal Hemorrhage/diagnosisABSTRACT
Colon capsule endoscopy is a wireless and minimally invasive technique for visualization of the whole colon. With recent improvements of technical features in second-generation systems, a more important role for colon capsule endoscopy is rapidly emerging. Although several limitations and drawbacks are yet to be resolved, its usefulness as a tool for colorectal cancer screening and monitoring disease activity in inflammatory bowel diseases has become more apparent with increased use. Further investigations, including multicenter trials, are required to evaluate the substantial role of the colon capsule in managing colorectal diseases.
Subject(s)
Capsule Endoscopy/trends , Colonic Diseases/diagnosis , Capsule Endoscopes/trends , Capsule Endoscopy/adverse effects , Capsule Endoscopy/methods , Colonic Polyps/diagnosis , Colonoscopy/adverse effects , Colonoscopy/methods , Colonoscopy/trends , Colorectal Neoplasms/diagnosis , Contraindications , Early Detection of Cancer/methods , Equipment Design/trends , Humans , Inflammatory Bowel Diseases/diagnosisABSTRACT
La enfermedad de Whipple es una infección sistémica crónica producida por el actinomiceto Tropheryma whipplei. Las pruebas endoscópicas son claves en el diagnóstico ya que permiten la toma de biopsia y su estudio anatomopatológico para el diagnóstico definitivo de esta entidad. Presentamos un caso de enfermedad de Whipple en el que la cápsula endoscópica, poco común para el diagnóstico de esta afección, fue clave para el mismo y su realización antes y después del tratamiento antibiótico permite describir la evolución macroscópica de los hallazgos en intestino delgado. Este caso ilustra la utilidad de la cápsula endoscópica al permitir un estudio completo del intestino delgado en esta enfermedad en la que hasta el 30% de los pacientes puede cursar con gastroscopia normal (AU)
Whipple´s disease is a chronic systemic infection produced by the actinomycete Tropheryma whipplei. Endoscopic tests are key in the diagnosis as they allow biopsy and histopathological examination for definitive diagnosis of this entity. We present a case of Whipple´s disease where capsule endoscopy, uncommon for the diagnosis of this condition, was essential for it and its performance before and after antibiotic treatment allows to describe the macroscopic evolution of the findings in the small bowel. This case illustrates the utility of capsule endoscopy to allow complete examination of the small bowel disease in which up to 30% of patients may present with normal endoscopy (AU)
Subject(s)
Humans , Male , Middle Aged , Whipple Disease/complications , Whipple Disease , Capsule Endoscopy/instrumentation , Capsule Endoscopy/methods , Capsule Endoscopy/trends , Capsule Endoscopes/trends , Capsule Endoscopes , Histiocytes/pathology , Histiocytes , Gastroscopy/instrumentation , Gastroscopy/methods , Gastroscopy , Xanthomatosis/complications , Xanthomatosis , Colonoscopy/methods , Colonoscopy/trends , ColonoscopyABSTRACT
Since its introduction into clinical practice 15 years ago, capsule endoscopy (CE) has become the first-line investigation procedure in some small bowel pathologies, and more recently, dedicated esophageal and colon CE have expanded the fields of application to include the upper and lower gastrointestinal disorders. During this time, CE has become increasingly popular among gastroenterologists, with more than 2 million capsule examinations performed worldwide, and nearly 3000 PubMed-listed studies on its different aspects published. This huge interest in CE may be explained by its non-invasive nature, patient comfort, safety, and access to anatomical regions unattainable via conventional endoscopy. However, CE has several limitations which impede its wider clinical applications, including the lack of therapeutic capabilities, inability to obtain biopsies and control its locomotion. Several research groups are currently working to overcome these limitations, while novel devices able to control capsule movement, obtain high quality images, insufflate the gut lumen, perform chromoendoscopy, biopsy of suspect lesions, or even deliver targeted drugs directly to specific sites are under development. Overlooking current limitations, especially as some of them have already been successfully surmounted, and based on the tremendous progress in technology, it is expected that, by the end of next 15 years, CE able to perform both diagnostic and therapeutic procedures will remain the major form of digestive endoscopy. This review summarizes the literature that prognosticates about the future developments of CE.
Subject(s)
Capsule Endoscopy/trends , Gastrointestinal Diseases/diagnosis , Animals , Biopsy , Capsule Endoscopes/trends , Drug Delivery Systems , Electric Power Supplies , Gastrointestinal Diseases/diagnostic imaging , Humans , InsufflationABSTRACT
Currently, the major problem of all existing commercial capsule devices is the lack of control of movement. In the future, with an interface application, the clinician will be able to stop and direct the device into points of interest for detailed inspection/diagnosis, and therapy delivery. This editorial presents current commercially-available new designs, European projects and delivery capsule and gives an overview of the progress required and progress that will be achieved -according to the opinion of the authors- in the next 5 year leading to 2020.
Subject(s)
Capsule Endoscopes/trends , Capsule Endoscopy/trends , Wireless Technology/trends , Capsule Endoscopy/instrumentation , Capsule Endoscopy/methods , Equipment Design , Forecasting , Humans , Miniaturization , Nanostructures , Nanotechnology/trends , Time FactorsABSTRACT
Colon capsule endoscopy (CCE; PillCam Colon; Given Imaging; Yoqneam, Israel) is a minimally invasive wireless technique for the visualization of the colon. With the recent introduction of the second generation colon capsule the diagnostic accuracy of CCE for polyp detection has significantly improved and preliminary data suggest it may be useful to monitor mucosal inflammation in patients with inflammatory bowel disease. Limitations include the inability to take biopsies and the procedural costs. However, given the potentially higher acceptance within an average risk colorectal cancer (CRC) screening population, its usefulness as a screening tool with regard to CRC prevention should be further evaluated.
Subject(s)
Capsule Endoscopy/trends , Colon/pathology , Colonic Diseases/pathology , Colonoscopy/trends , Capsule Endoscopes/trends , Capsule Endoscopy/instrumentation , Colonoscopy/instrumentation , Contraindications , Diffusion of Innovation , Equipment Design , History, 21st Century , Humans , Patient Selection , Predictive Value of Tests , PrognosisABSTRACT
2013 saw several advances in small bowel endoscopy: new 3D visualization software, increased battery life, side-viewing cameras and higher frame rate. Studies on prokinetics for patient preparation, safety in the elderly, rebleeding after negative capsule endoscopy and defining optimum training requirements for fellows were encouraging. Procedure time and small bowel length evaluated by double-balloon and spiral endoscopy were shown to be comparable.
Subject(s)
Endoscopy, Gastrointestinal/methods , Endoscopy, Gastrointestinal/trends , Capsule Endoscopes/trends , Endoscopy, Gastrointestinal/instrumentation , Humans , Imaging, Three-Dimensional/instrumentation , Imaging, Three-Dimensional/methods , Imaging, Three-Dimensional/trends , Professional Competence/standardsABSTRACT
AIM: To study the current application situation of gastrointestinal (GI) endoscopy in mainland China. METHODS: From 12 August, 2011 to 15 February, 2012, draft questionnaires were sent by e-mail to 289 hospital-based GI endoscopy units, including units with three levels (provincial, prefecture and county level) in mainland China. All the surveyed GI endoscopy units were state-owned and hospital-based. Proportions were compared using χ² tests. Comparisons between groups were performed using the Mann-Whitney U test. A probability of P < 0.05 was considered to represent a statistically significant difference. RESULTS: Based on satisfactory replies, 169/279 (60.6%) of units were enrolled in the survey, which covered 28 provinces (90.3%, 28/31) in mainland China. Compared with published survey data, the number of GI endoscopes per unit has increased by nearly three times (from 2.9 to 9.3) in the past decade. About 33 of 169 (19.5%) endoscopy units possessed an X-ray machine, which was mainly owned by provincial endoscopy units (43.2%, 19/44). Video capsule endoscopes, which were almost unavailable ten years ago, were owned by 20.7% (35/169) of GI endoscopy units. Endoscopic submucosal dissection could be performed by 36.4% (19/44) of the provincial units, which was significantly higher than the prefecture level (9.9%, P < 0.01) and county level (0.0%, P < 0.01) units, respectively. CONCLUSION: Rapid development in GI endoscopy has been made in mainland China, and major diagnostic endoscopes and therapeutic endoscopy procedures are predominantly used in large endoscopy units.
Subject(s)
Endoscopy, Gastrointestinal/trends , Practice Patterns, Physicians'/trends , Capsule Endoscopes/trends , Capsule Endoscopy/trends , Chi-Square Distribution , China , Diffusion of Innovation , Endoscopes, Gastrointestinal/trends , Health Care Surveys , Humans , Surveys and Questionnaires , Time FactorsABSTRACT
Background: capsule endoscopy (CE) has revolutionized the study of small bowel. One major drawback of this technique is that we cannot interfere with image acquisition process. Therefore, the development of new software tools that could modify the images and increase both detection and diagnosis of small-bowel lesions would be very useful. The Flexible Spectral Imaging Color Enhancement (FICE) that allows for virtual chromoendoscopy is one of these software tools. Aims: to evaluate the reproducibility and diagnostic accuracy of the FICE system in CE. Methods: this prospective study involved 20 patients. First, four physicians interpreted 150 static FICE images and the overall agree - ment between them was determined using the Fleiss Kappa Test. Second, two experienced gastroenterologists, blinded to each other results, analyzed the complete 20 video streams. One interpreted conventional capsule videos and the other, the CE-FICE videos at setting 2. All findings were reported, regardless of their clinical value. Non-concordant findings between both interpretations were analyzed by a consensus panel of four gastroenterologists who reached a final result (positive or negative finding). Results: in the first arm of the study the overall concordance between the four gastroenterologists was substantial (0.650). In the second arm, the conventional mode identified 75 findings and the CE-FICE mode 95. The CE-FICE mode did not miss any lesions identified by the conventional mode and allowed the identification of a higher number of angiodysplasias (35 vs 32), and erosions (41 vs. 24). Conclusions: there is reproducibility for the interpretation of CE-FICE images between different observers experienced in conventional CE. The use of virtual chromoendoscopy in CE seems to increase its diagnostic accuracy by highlighting small bowel erosions and angiodysplasias that werent identified by the conventional mode(AU)
Subject(s)
Humans , Male , Female , Capsule Endoscopes/standards , Capsule Endoscopes , Capsule Endoscopy/methods , Capsule Endoscopy/trends , Capsule Endoscopy , Video-Assisted Surgery/methods , Video-Assisted Surgery/trends , Capsule Endoscopes/trends , Prospective Studies , Video-Assisted Surgery/standards , Video-Assisted SurgeryABSTRACT
Background: in 21st century, endoscopic study of the small intestine has undergone a revolution with capsule endoscopy and balloon-assisted enteroscopy. The difficulties and morbidity associated with intraoperative enteroscopy, the gold-standard in the 20th century, made this technique to be relegated to a second level. Aims: evaluate the actual role and assess the diagnostic and therapeutic value of intraoperative enteroscopy in patients with obscure gastrointestinal bleeding. Patients and methods: we conducted a retrospective study of 19 patients (11 males; mean age: 66.5 ± 15.3 years) submitted to 21 IOE procedures for obscure GI bleeding. Capsule endoscopy and double balloon enteroscopy had been performed in 10 and 5 patients, respectively. Results: with intraoperative enteroscopy a small bowel bleeding lesion was identified in 79% of patients and a gastrointestinal bleed - ing lesion in 94%. Small bowel findings included: angiodysplasia (n = 6), ulcers (n = 4), small bowel Dieulafoys lesion (n = 2), bleed - ing from anastomotic vessels (n = 1), multiple cavernous hemangiomas (n = 1) and bleeding ectopic jejunal varices (n = 1). Agree - ment between capsule endoscopy and intraoperative enteroscopy was 70%. Endoscopic and/or surgical treatment was used in 77.8% of the patients with a positive finding on intraoperative enteroscopy, with a rebleeding rate of 21.4% in a mean 21-month follow-up period. Procedure-related mortality and postoperative complications have been 5 and 21%, respectively. Conclusions: intraoperative enteroscopy remains a valuable tool in selected patients with obscure GI bleeding, achieving a high diagnostic yield and allowing an endoscopic and/or surgical treatment in most of them. However, as an invasive procedure with relevant mortality and morbidity, a precise indication for its use is indispensable(AU)
Subject(s)
Humans , Male , Female , Double-Balloon Enteroscopy/methods , Double-Balloon Enteroscopy , Gastrointestinal Hemorrhage/complications , Gastrointestinal Hemorrhage/diagnosis , Capsule Endoscopes/trends , Capsule Endoscopes , Intestine, Small , Retrospective Studies , Hemangioma/complications , Hemangioma/diagnosis , MorbidityABSTRACT
Capsule endoscopy (CE) has evolved in a few short years to become a first-line, noninvasive diagnostic technique for the small bowel. CE is now being utilized worldwide to assess patients for obscure gastrointestinal bleeding, possible Crohn's disease, celiac disease and small bowel tumors. The device is now used in tandem with balloon enteroscopy to direct therapeutic interventions. Alterations and improvements in CE have also led to the evaluation of both the esophagus and colon. It can be anticipated that in the near future pan CE of the entire GI tract will be performed, as well as possible tissue acquisition, drug delivery and therapeutic interventions.